GlassScriptPhysician profile
Scott L Mikell
NPI 1386056422
$9,892.65
in general payments reported to CMS, 2019-2025
48 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 95% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $878 · 2021: $1,317 · 2022: $1,571 · 2023: $1,889 · 2024: $1,882 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,457.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,125.01 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $882.67 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $816.95 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $813.97 | 2021-2025 | |
| Pfizer INC. | $710.34 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $688.72 | 2019-2025 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $509.39 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lundbeck LLC | $293.98 | 2023-2025 | Rexulti |
| Dexcom, INC. | $247.86 | 2021-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $217.23 | 2020-2025 | Januvia, Belsomra, Steglatro |
| Glaxosmithkline, LLC. | $216.85 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $207.32 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $187.56 | 2020-2025 | Trintellix |
| Kowa Pharmaceuticals America, INC. | $187.13 | 2019-2023 | Livalo, Seglentis |
| Esperion Therapeutics, INC. | $186.82 | 2020-2024 | Nexletol |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $177.17 | 2022-2025 | Rexulti, Nuedexta |
| Bayer Healthcare Pharmaceuticals INC. | $175.08 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $159.25 | 2019-2022 | |
| Tris Pharma INC | $151.08 | 2023-2025 | Dyanavel Xr |
| Amarin Pharma, INC. | $146.19 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.08 | 2023-2025 | Xifaxan, Trulance |
| Axsome Therapeutics, INC. | $136.90 | 2024-2025 | Auvelity |
| Abbott Laboratories | $131.27 | 2021-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $119.20 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Teva Pharmaceuticals USA, INC. | $110.47 | 2020-2024 | Austedo Xr, Airduo Digihaler |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $106.94 | 2024-2025 | Caplyta |
| Antares Pharma, INC. | $100.57 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $98.02 | 2022-2024 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $87.45 | 2021 | |
| Corium, LLC | $87.08 | 2023 | Azstarys |
| Boston Scientific Corporation | $77.24 | 2023-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Ironshore Pharmaceuticals INC. | $72.88 | 2019-2024 | |
| Harmony Biosciences LLC | $63.68 | 2022-2024 | Wakix |
| Biohaven Pharmaceutical Holding Company LTD. | $61.32 | 2022 | |
| Vanda Pharmaceuticals INC. | $56.40 | 2025 | Fanapt |
| Astellas Pharma US INC | $44.23 | 2023-2024 | Veozah |
| Allergan, INC. | $43.44 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $38.42 | 2024-2025 | Voquezna |
| Eisai INC. | $32.17 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $30.66 | 2023-2025 | Spravato, Xarelto |
| Shire North American Group INC | $29.28 | 2019 | |
| Genentech USA, INC. | $26.61 | 2020-2021 | |
| Corcept Therapeutics | $23.54 | 2025 | Korlym |
| Sanofi Pasteur INC. | $21.42 | 2023 | |
| Alexion Pharmaceuticals, INC. | $14.64 | 2019 | |
| Bausch Health US, LLC | $14.48 | 2021 | |
| Gilead Sciences, INC. | $13.91 | 2021 | |
| Upsher-Smith Laboratories LLC | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mikell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.